Satellos Bioscience Inc.: Satellos Bioscience Announces Clos

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) (OTCQB: MSCLF) ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics

Related Keywords

United States , Toronto , Ontario , Canada , Christina Cameron , Ryan Mitchell , Michael Rudnicki , Geoff Mackay , Frank Gleeson , William Jarosz , Satellos Bioscience Inc , Company The Debentures , Company Board , Venture Exchange , Regulatory Services Provider , Communications At Satellos Bioscience Inc , Newsfile Corp , Business Development , Each Unit , Board Chair , Multilateral Instrument , Minority Security Holders , Special Transactions , Maturity Date , Closing Date , Bonus Shares , Satellos Bioscience , Diese Gold Aktie , Sichern Sie , Satellos , Ioscience , Nnounces , Closing , Reviously , Nnounced , Rokered , Offering , Billion , Insecured , Convertible , Debentures ,